UTHR

312.99

0.19% -0.61

Vorhandelsmarkt: 313.51 0.52 +0.17%

United Therapeutics Corp (UTHR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt UTHR? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$313.60

Offen:

$311.18

24-Stunden-Volumen:

1.13M

Relative Volume:

2.75

Marktkapitalisierung:

$14.06B

Einnahmen:

$2.76B

Nettoeinkommen (Verlust:

$1.11B

KGV:

13.75

EPS:

22.77

Netto-Cashflow:

$898.10M

1W Leistung:

+1.87%

1M Leistung:

-13.32%

6M Leistung:

-11.33%

1J Leistung:

+32.10%

1-Tages-Spanne:

$308.43

$315.69

1-Wochen-Bereich:

$304.55

$324.57

52-Wochen-Spanne:

$221.53

$417.81

United Therapeutics Corp Stock (UTHR) Company Profile

Firmenname

United Therapeutics Corp

Sektor

Healthcare (1166)

Branche

Biotechnology (675)

Telefon

(301) 608-9292

Adresse

1000 SPRING ST, SILVER SPRING, MD

Mitarbeiter

1,305

Twitter

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

UTHR's Discussions on Twitter

Vergleichen Sie UTHR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
UTHR United Therapeutics Corp	312.99	14.06B	2.76B	1.11B	898.10M	22.77
VRTX Vertex Pharmaceuticals Inc	503.20	129.22B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	658.48	71.99B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	615.02	37.37B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	283.34	36.68B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	251.98	27.10B	3.81B	-644.79M	-669.77M	-6.24

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-07-11	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-02-12	Hochstufung	Goldman	Sell → Neutral
2024-02-05	Eingeleitet	Leerink Partners	Outperform
2023-12-08	Eingeleitet	Wells Fargo	Overweight
2022-12-06	Eingeleitet	UBS	Buy
2022-12-05	Eingeleitet	Goldman	Sell
2022-10-11	Eingeleitet	Morgan Stanley	Overweight
2022-09-20	Bestätigt	BofA Securities	Underperform
2022-09-19	Fortgesetzt	Wedbush	Outperform
2022-02-11	Eingeleitet	BTIG Research	Neutral
2021-07-14	Hochstufung	Argus	Hold → Buy
2021-04-26	Fortgesetzt	Credit Suisse	Outperform
2021-02-01	Hochstufung	H.C. Wainwright	Neutral → Buy
2020-09-14	Fortgesetzt	JP Morgan	Overweight
2020-06-25	Bestätigt	H.C. Wainwright	Neutral
2020-03-10	Hochstufung	Jefferies	Hold → Buy
2020-02-27	Hochstufung	Cowen	Market Perform → Outperform
2020-01-31	Hochstufung	JP Morgan	Neutral → Overweight
2019-12-03	Eingeleitet	BofA/Merrill	Underperform
2019-08-01	Hochstufung	Jefferies	Underperform → Hold
2019-08-01	Hochstufung	Ladenburg Thalmann	Neutral → Buy
2019-07-01	Hochstufung	Credit Suisse	Neutral → Outperform
2019-05-17	Hochstufung	UBS	Sell → Neutral
2019-05-09	Hochstufung	Credit Suisse	Underperform → Neutral
2018-10-12	Hochstufung	Standpoint Research	Hold → Buy
2018-08-08	Herabstufung	Credit Suisse	Neutral → Underperform
2018-04-03	Hochstufung	Credit Suisse	Underperform → Neutral
2018-02-22	Bestätigt	Barclays	Underweight
2018-01-18	Fortgesetzt	Credit Suisse	Underperform
2017-12-27	Bestätigt	Wedbush	Outperform
2017-04-27	Bestätigt	Wedbush	Outperform
2017-03-30	Eingeleitet	UBS	Sell
2017-03-16	Eingeleitet	Credit Suisse	Underperform

Alle ansehen

United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten

Mar 20, 2025

United Therapeutics director sells $1.55 million in stock By Investing.com - Investing.com Canada

Mar 20, 2025

United Therapeutics director sells $1.55 million in stock - Investing.com India

Mar 20, 2025

Market Turbulence? These 20 Stocks Boast a Perfect Piotroski Score and 40%+ Upside - Investing.com

Mar 20, 2025

Mar 19, 2025

United Therapeutics price target lowered to $314 from $328 at BofA - TipRanks

Mar 19, 2025

Exosome Therapy Market Market Is Booming Worldwide 2025-2032 | - openPR

Mar 19, 2025

Mar 14, 2025

Is United Therapeutics Corporation (UTHR) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey

Mar 14, 2025

Mar 12, 2025

United Therapeutics president Michael Benkowitz sells $640k in stock By Investing.com - Investing.com Australia

Mar 12, 2025

Mar 11, 2025

For patients needing transplants, hope arrives on tiny hooves - The Spokesman Review

Mar 11, 2025

United Therapeutics president Michael Benkowitz sells $640k in stock - Investing.com

Mar 11, 2025

Mar 04, 2025

What Will United Therapeutics Reveal at the Leerink Conference? Key Details for Investors - StockTitan

Mar 04, 2025

Mar 03, 2025

Top Executives Cash In on United Therapeutics Stock! - TipRanks

Mar 03, 2025

Ray Kurzweil Sells 15,000 Shares of United Therapeutics Corp - GuruFocus.com

Mar 03, 2025

United Therapeutics director Thompson sells $795,837 in stock By Investing.com - Investing.com Canada

Mar 03, 2025

United Therapeutics director Thompson sells $795,837 in stock - Investing.com India

Mar 03, 2025

Silver Spring's United Therapeutics to Begin Clinical Study of Groundbreaking UKidney™ (Pig Organ) Transplant - The MoCoShow

Mar 03, 2025

Q2 EPS Estimate for United Therapeutics Lowered by Analyst - Defense World

Mar 03, 2025

Mar 01, 2025

Oppenheimer Asset Management Inc. Sells 6,988 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Mar 01, 2025

Bank of New York Mellon Corp Sells 1,693 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Mar 01, 2025

United Therapeutics Receives FDA Approval for Pig Organ Clinical Trials - Source of the Spring

Mar 01, 2025

United Therapeutics (NASDAQ:UTHR) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 01, 2025

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by New York State Common Retirement Fund - MarketBeat

Mar 01, 2025

Feb 28, 2025

Weil Company Inc. Has $449,000 Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Feb 28, 2025

United Therapeutics (NASDAQ:UTHR) Releases Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat

Feb 28, 2025

United Therapeutics (NASDAQ:UTHR) Shares Gap Down Following Insider Selling - MarketBeat

Feb 28, 2025

United Therapeutics Co. (NASDAQ:UTHR) Stock Position Boosted by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat

Feb 28, 2025

United Therapeutics (NASDAQ:UTHR) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat

Feb 28, 2025

Los Angeles Capital Management LLC Has $36.55 Million Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Feb 28, 2025

Truist Financial Corp Sells 2,920 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Feb 28, 2025

United Therapeutics Co. (NASDAQ:UTHR) COO Michael Benkowitz Sells 10,000 Shares - MarketBeat

Feb 28, 2025

Atria Wealth Solutions Inc. Invests $412,000 in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Feb 28, 2025

Lung transplant technology collaboration between Mayo Clinic Florida and United Therapeutics - Florida Trend

Feb 28, 2025

Feb 27, 2025

United Therapeutics Corp. Reports Record Revenue and Growth - TipRanks

Feb 27, 2025

United Therapeutics Corp. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

United Therapeutics Reports Record Revenue in Q4 2024, Advances Strategic Growth - HPBL

Feb 27, 2025

United Therapeutics Corporation (NASDAQ:UTHR) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025

Goldman Sachs cuts United Therapeutics stock target to $293 By Investing.com - Investing.com Australia

Feb 27, 2025

Goldman Sachs cuts United Therapeutics stock target to $293 - Investing.com

Feb 27, 2025

United Therapeutics: Q4 Earnings Snapshot - Thehour.com

Feb 27, 2025